相关实验视频
Updated: Feb 26, 2026
16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
36.1K
在美国左心室辅助装置植入和心脏移植后的短期护理负担
Balaphanidhar Mogga1, Ashwin Pillai2, Karanrajsinh Raol1
1Department of Internal Medicine, St Vincent's Medical Center Frank H Netter School of Medicine/Quinnipiac University Bridgeport CT USA.
Journal of the American Heart Association
|February 24, 2026
概括
心脏移植 (HT) 和左心室辅助器件 (LVAD) 显示出类似的短期护理负担和再住院风险. 这项研究比较了接受HT或LVAD的晚期心力衰竭患者的结果和成本.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 医疗保健服务研究 医疗服务研究
背景情况:
- 晚期心力衰竭需要先进的治疗方法,如心脏移植 (HT) 和左心室辅助装置 (LVAD).
- 从历史上看,LVADs作为目的地治疗或桥梁到移植,但不断变化的分配政策造成了不确定性.
- 在HT和LVAD之间,短期护理负担的比较还不清楚.
研究的目的:
- 为了比较HT与LVAD接受者的患者特征,结果和指数住院和随后的再入院期间的成本.
- 分析与这些先进的心力衰竭治疗相关的短期资源利用和再住院模式.
主要方法:
- 利用全国 Readmissions 数据库 (2018-2021) 进行大规模分析.
- 使用特定的ICD-10-CM程序代码进行心脏移植 (HT) 和耐用左心室辅助装置 (LVAD) 植入的患者的确定的队列.
- 医院住院指数数据和30/90天再入院特征,结果和成本的比较.
主要成果:
- 接受LVAD治疗的患者 (52.4%) 年龄较大,更有可能是男性,社会经济地位较低,住院时间较长,比接受HT治疗的患者更昂贵.
- 较高比例的LVAD接受者需要重新住院30天,主要是因为心力衰竭,设备并发症和胃肠道出血.
- 接受HT的患者经历了更高的30日和90天再入院费用,常见原因包括移植并发症,功能障碍和败血症.
结论:
- 心脏移植和LVAD对医疗保健资源和短期再住院风险构成相似的负担.
- 了解这些比较负担对于资源配置和高级心力衰竭护理中的患者管理至关重要.
相关概念视频
01:29Cardiomyopathy V: Interprofessional Care
520
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
520
01:22Heart Failure VI: Adjunct Therapies
442
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
442
01:30Cardiomyopathy II: Dilated Cardiomyopathy
649
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
649
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
555
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
555
01:21Cardiac Catheterization II: Right Heart Catheterization
1.3K
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
1.3K
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
398
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
398